-
Shuangcheng pharmaceutical focuses on clinical re declaration after withdrawal of etibatide for injection
Time of Update: 2020-04-03
Hainan Shuangcheng Pharmaceutical Co., Ltd
focuses on the research of etibatide, which has attracted market attention since the withdrawal of registration application
-
What is hydrogel injection
Time of Update: 2020-04-03
Repeated injection several times at the same point, then massage the buttocks to distribute the hydrogel evenly, and get the desired shape.
-
Approved production of Lansoprazole for injection
Time of Update: 2020-04-03
According to the website of CFDA on April 11, the status of Lansoprazole for injection of class 3 new drugs of Jiangsu Wuzhong Pharmaceutical Group changed to "certificate preparation completed - approval document issued in Jiangsu Province".
-
Huabang pharmaceutical "methylprednisolone sodium succinate for injection" obtained drug registration approval
Time of Update: 2020-04-03
In the evening of June 11, Huabang Yingtai announced that its wholly-owned subsidiary Chongqing Huabang pharmaceutical's "methylprednisolone sodium succinate for injection" had
-
Nanjing jianyouda heparin sodium injection and low molecular weight heparin calcium injection were inspected on site this month
Time of Update: 2020-04-03
According to the website of the State Food and Drug Administration (CFDA) on June 17, the daparin sodium injection and low molecular weight heparin calcium injection declared
-
Patent for irinotecan hydrochloride injection and its preparation
Time of Update: 2020-04-03
As of September 2013, in the domestic sample hospital irinotecan market, "Eli" of Hengrui pharmaceutical, "yimeilin" of Qilu pharmaceutical, and "keputuo" of Pfizer pharmaceutical have formed a tripartite competition pattern.
-
Clinical approval for ceftetan disodium injection and API
Time of Update: 2020-04-03
After obtaining the official clinical approval documents of cefotetan disodium for injection and raw materials, the company needs to carry out clinical research.
-
PNAs: intratumoral injection of influenza vaccine or enhancement of anti-cancer immunotherapy
Time of Update: 2020-02-19
Based on these findings, the authors suggest that injecting a clinically approved influenza vaccine into a tumor to an accessible metastatic tumor will have dual benefits, providing anti influenza protection and anti-cancer immune infiltration.
-
Anda of Zhengda Tianqing fluvistrone injection was approved and approved for listing in Germany
Time of Update: 2020-02-12
On February 11, China biopharmaceutical announced that its subsidiary company Zhengda Tianqing's anti breast cancer drug "fluvectin injection" has been approved by the FDA
-
Moxifloxacin hydrochloride injection approved for marketing
Time of Update: 2020-01-15
On January 15, Peking University Pharmaceutical announced that the company had received the registration approval of moxifloxacin hydrochloride injection approved and issued
-
Release of technical guidelines for research of paclitaxel (albumin binding) generic drugs for injection
Time of Update: 2020-01-08
On January 8, CDE official website released the notice on "technical guidelines for research on generic drugs of paclitaxel for injection (albumin binding type)" (Draft for comments).
-
Jianyou shares bensulfosan atracurium injection obtained notice of clinical trial
Time of Update: 2020-01-06
In January 1996, nimbex was first approved for listing in Denmark.
-
Nature: intravenous injection can significantly improve the efficacy of tuberculosis vaccine
Time of Update: 2020-01-04
January 4, 2020 / Bio Valley BIOON / - -- globally, although the vast majority of people have been vaccinated, the number of people who die of tuberculosis still exceeds
-
Haizheng [adamumumab injection] pricing announced
Time of Update: 2020-01-03
On January 2, Shaanxi provincial centralized procurement network of pharmaceutical machinery released the announcement on direct network hanging of adamumumab injection
-
Pricing of Haizheng adamumumab injection in Shaanxi
Time of Update: 2020-01-02
[January 2, 2020 / medical information list] the new version of the medical insurance catalogue has been implemented, Changfeng pharmaceutical has completed 630 million e rounds
-
Paclitaxel injection of Huiyu pharmaceutical is to be included in the priority review
Time of Update: 2019-12-27
On December 25, CDE official website showed that Huiyu pharmaceutical's Paclitaxel injection was proposed to be included in the priority review for the reason that "the same
-
Conbercept ophthalmic injection global phase III clinical subjects into the group completed
Time of Update: 2019-12-25
On December 25, 2019, Chengdu Kanghong Pharmaceutical Group Co., Ltd
released the progress announcement of the clinical trial project of conbercept ophthalmic injection
-
Lizhu group vancomycin hydrochloride for injection has been approved for marketing
Time of Update: 2019-12-24
According to the database on the official website of the State Drug Administration, as of the date of this announcement, there are 6 domestic enterprises (including Lizhu pharmaceutical factory of Lizhu group) approved for listing vancomycin hydrochloride for injection.
-
Agarase β for injection of drugs for rare diseases is approved for marketing
Time of Update: 2019-12-20
The approval of this product will bring good news for the treatment of domestic patients with Fabry disease.
-
Note that there is great progress in the evaluation of chemical injection consistency
Time of Update: 2019-12-12
Until March 29, 2019, the drug evaluation center of the State Food and Drug Administration issued the catalogue of chemical generic reference preparations (the 21st batch), involving 327 varieties in total, the pace of work began to accelerate.
